Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 of  56,250 نتائج ""Bone Density""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.

  • Authors : Miyamura G; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.; Wakabayashi H

Subjects: Bone Density*; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*therapeutic use ; Diphosphonates/Diphosphonates/Diphosphonates/*therapeutic use

  • Source: Modern rheumatology [Mod Rheumatol] 2021 May; Vol. 31 (3), pp. 733-742. Date of Electronic Publication: 2020 Jul 10.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 100959226 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Editorial & Opinion

Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.

Subjects: Bone Density Conservation Agents* ; Osteoporosis, Postmenopausal*; Bone Density

  • Source: Endocrine [Endocrine] 2021 Jul; Vol. 73 (1), pp. 223-225. Date of Electronic Publication: 2021 Mar 02.Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Bone targeting nanocarrier-assisted delivery of adenosine to combat osteoporotic bone loss.

  • Authors : Hoque J; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.; Shih YV

Subjects: Bone Density Conservation Agents* ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy; Adenosine

  • Source: Biomaterials [Biomaterials] 2021 Jun; Vol. 273, pp. 120819. Date of Electronic Publication: 2021 Apr 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.

  • Authors : Wu Y; School of Rehabilitation Medicine, Capital Medical University, Beijing, China.; Wang F

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Osteoporosis*/Osteoporosis*/Osteoporosis*/etiology

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.

  • Authors : Lyles KW; Duke University School of Medicine, Durham, NC, USA. .; GRECC, VA Medical Center, Durham, NC, USA. .

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Hip Fractures*/Hip Fractures*/Hip Fractures*/prevention & control ; Hip Fractures*/Hip Fractures*/Hip Fractures*/surgery

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.

  • Authors : Sølling AS; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. .; Christensen DH

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis, Postmenopausal*; Alendronate/Alendronate/Alendronate/therapeutic use

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Effect of lumbar spinal stenosis on bone mineral density in osteoporosis patients treated with ibandronate.

  • Authors : Park HY; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea.; Ha JY

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/diagnostic imaging ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy

  • Source: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2021 May 04; Vol. 22 (1), pp. 412. Date of Electronic Publication: 2021 May 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474

تفاصيل السجل

×
Academic Journal

Overview of treatment approaches to osteoporosis.

  • Authors : Langdahl BL; Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy; Bone Density

  • Source: British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (9), pp. 1891-1906. Date of Electronic Publication: 2020 Mar 20.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

تفاصيل السجل

×
Academic Journal

Real-world bone turnover marker use: impact on treatment decisions and fracture.

  • Authors : Lane NE; Department of Internal Medicine, UC Davis Health, Sacramento, CA, USA. .; Saag K

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Fractures, Bone* ; Osteoporosis*/Osteoporosis*/Osteoporosis*/diagnosis

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

High persistence over two years with denosumab among postmenopausal women with osteoporosis in France: A prospective cohort study.

  • Authors : Briot K; Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.; Schott AM

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis* ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: Bone [Bone] 2021 May; Vol. 146, pp. 115890. Date of Electronic Publication: 2021 Feb 18.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
  • 1-10 of  56,250 نتائج ""Bone Density""